Cutera

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Cutera sits in the top decile of US sponsors by registered trial count (#456 of 15,742 sponsors by registered trial count).

37 total trials none currently recruiting 33 completed later-stage tilt top decile by trial count

Cutera: 37 sponsored US clinical trials, none currently recruiting.

Cutera sponsors 37 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 33 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Body Fat, with 2 trials.

Top-decile sponsor footprint

Cutera ranks in the top decile of sponsors by registered trial count (#456 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

33 of 36 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

37 total, page 1 of 1

ACTIVE NOT RECRUITING NA

A Post Market Device Study for the Treatment of Acne

NCT06469398

COMPLETED NA

A Device Study for the Treatment of Acne

NCT04695691

COMPLETED NA

Multi-Center Pilot Study of Cutera truSculpt Device

NCT03782545

COMPLETED NA

Open-label, Prospective, Multicenter Study to Evaluate the Cutera Excel V™ Laser and a Micro-Lens Array Attachment

NCT03424148

COMPLETED NA

Multi-Center, Clinical Evaluation of the Cutera Secret RF Device

NCT03424161

COMPLETED NA

Evaluation of Cutera Excel V™ Laser With Green Genesis and Micro-Lens Array (MLA)Attachment

NCT03424304

COMPLETED NA

Multi-Center Pilot Study of truSculpt Device

NCT03433430

COMPLETED NA

Pivotal Study of the Cutera truSculpt Radiofrequency Device for Wrinkle Reduction

NCT03285581

COMPLETED NA

Evaluation of the Cutera Enlighten™ Laser With Micro-Lens Array (MLA) Handpiece Attachment

NCT03430921

COMPLETED NA

enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars

NCT03284333

COMPLETED

Long-term Follow-up Study of the truSculpt Radiofrequency Device for Circumferential Reduction

NCT03428243

COMPLETED NA

Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat

NCT03433417

COMPLETED NA

Feasibility Study of the TruSculpt Radiofrequency Device

NCT03018587

COMPLETED NA

Multi-Wavelength Laser Tattoo Removal Pivotal Study

NCT02935660

COMPLETED NA

A Study of a Novel Multi-Wavelength Laser for Tattoo Removal

NCT02910505

COMPLETED NA

Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal

NCT02912507

COMPLETED NA

Study of a Novel Laser for Skin Rejuvenation

NCT02910492

COMPLETED NA

Study of a Novel Microlens Array Device for Skin Rejuvenation

NCT02888626

COMPLETED NA

A Clinical Evaluation of the Treatment of Spider Veins on the Ankles

NCT02754479

COMPLETED NA

Clinical Evaluation of the Treatment of Spider Angioma

NCT02755467

COMPLETED NA

A Single-Center 2-Arm Study for Lentigines on the Hands

NCT02763072

TERMINATED NA

A Clinical Evaluation for Tattoo Removal

NCT02756806

COMPLETED NA

A Single-Center Open-Label Study of 1064 nm for Nonablative Skin Rejuvenation

NCT03421691

COMPLETED NA

Pivotal Study of the truSculpt Radiofrequency Device for Circumferential Reduction

NCT02873104

COMPLETED NA

A Clinical Evaluation of a Novel Multi-Wavelength Laser for Benign Pigmented Lesion Removal

NCT02635880

COMPLETED NA

Pilot Study of Multi-wavelength Laser for Tattoo Removal

NCT03290547

COMPLETED NA

Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea

NCT02268474

COMPLETED NA

Comparison Study of Picosecond and Nanosecond Pulse Durations Using a Q-switched Nd:YAG Laser for Tattoo Removal

NCT02244554

COMPLETED NA

Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair

NCT01912950

COMPLETED NA

Study of Picosecond and Nanosecond Q-switched Lasers for Tattoo Removal

NCT01973166

COMPLETED NA

Laser Removal of Age (Sun) Spots on Hands

NCT01885871

COMPLETED NA

Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars

NCT01789346

COMPLETED NA

The Trusculpt (Radio Frequency) Device For Thigh Circumference Reduction

NCT01665118

COMPLETED NA

Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte

NCT01491620

COMPLETED Phase 4

Treatment of Lower Extremity Spider Veins With Excel V

NCT01362192

TERMINATED NA

Radio Frequency (RF) Device for Reduction in Size of Localized Areas of the Body

NCT00953160

TERMINATED NA

Thigh Circumference Reduction Study

NCT00953290

How the Cutera archive is shaped

37 indexed studies, none listed as recruiting (0% open); 33 completed (89%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Body Fat (2 trials), 8 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Cutera: archived-pipeline peers nationwide

Peers matched on 37 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Cutera sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 010203040 0%5%10%15% Total trials Recruiting share CuteraAppalachian State UniversityBracco DiagnosticsCarnegie Mellon UniversityHarvard University10xBio22nd Century Group23andMe3-C Institute for Social Development
Cutera sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Cutera sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 37 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Cutera page

37 registered trials is a research-attention snapshot, not an endorsement of Cutera or any single study.

  • None of Cutera's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Body Fat is the condition Cutera studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Body Fat trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Cutera pipeline card: 37 registered trials from official public datasets.Report a data error.